Catalyst Wire Dossier Catalyst Wire Dossier

PS-Omega3 Supplementation

Omega-3 fatty acid supplementation · Tel-Aviv Sourasky Medical Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PS-Omega3 Supplementation, covering 2008-06-18 to 2008-06-18. Get the full timeline:

Most recent: Clinical Trial Update: PS-Omega3 Supplementation to Attention Deficit Hyperactivity Disorder (ADHD) Children [Phase 2]

See pricing